Paragard IUD Marketing & Claimant Acquisition

The litigation landscape

Federal cases are consolidated in an MDL in the Northern District of Georgia, where the litigation has matured through discovery toward bellwether workups — the stage at which settlement posture historically forms in device MDLs. The core liability story is failure to warn: the fracture risk appears in adverse event data reaching back years before the label meaningfully addressed removal breakage.

Claim quality turns on the operative record: a documented fracture during removal, imaging showing retained fragments, and the retrieval procedure that followed. That paper trail makes Paragard one of the cleaner screening exercises in device litigation.

Who a campaign targets

Screening criteria in Paragard matters typically include:

• Paragard IUD placement documented in medical records
• Device fracture at or after removal — arms breaking, fragments retained in the uterus
• Medical intervention to address the fragments: imaging, hysteroscopy, surgical retrieval, or hysterectomy
• Claims within the applicable limitations period, generally running from the fracture and retrieval events

How MTAA runs Paragard IUD campaigns

The audience is precise: women who had a copper IUD removed and experienced complications — an experience specific enough that creative describing it screens itself. Meta's reach into women's health audiences, run with the platform-policy care that category demands, produces qualified inquiries because the fact pattern is unmistakable to the women who lived it.

MTAA's Paragard campaigns screen on the three record-provable facts — placement, fracture, retrieval — so intake files arrive ready for records requests.